Department of Health Sciences, State University of Maringá, Maringá, Paraná, Brazil.
Department of Medicine, Federal University of Paraná, Curitiba, Paraná, Brazil.
Asian Pac J Cancer Prev. 2024 Aug 1;25(8):2703-2710. doi: 10.31557/APJCP.2024.25.8.2703.
To assess the influence of the COVID-19 pandemic on breast cancer screening.
This was a cross-sectional and retrospective study, which used data extracted from "TABNET" between 2014 to 2020. Statistical analysis was carried out using the ANOVA model.
In 2019, a total of 3,068,776 mammograms were conducted, which significantly decreased to 1,808,765 in 2020. Since the onset of the pandemic in Brazil in March 2020, there has been a reduction in the number of mammograms performed. Mammography coverage increased from 0.11 to 0.18 between 2014 and 2019 but sharply declined from 0.18 to 0.10 between 2019 and 2020.
The COVID-19 pandemic has had a detrimental impact on breast cancer screening efforts, especially in detecting the disease in early stages. Health services shifted their focus towards caring for COVID-19 patients, therefore neglecting routine screening programs and interventions. Additionally, the population's fear of contagion contributed to a decrease in demand for screening tests.
评估 COVID-19 大流行对乳腺癌筛查的影响。
这是一项横断面和回顾性研究，使用了 2014 年至 2020 年间从“TABNET”提取的数据。使用方差分析模型进行统计分析。
2019 年共进行了 3068776 次乳房 X 光检查，2020 年显著减少至 1808765 次。自 2020 年 3 月巴西 COVID-19 大流行开始以来，进行的乳房 X 光检查数量有所减少。乳房 X 光检查覆盖率从 2014 年至 2019 年的 0.11 增加到 0.18，但从 2019 年至 2020 年急剧下降到 0.10。
COVID-19 大流行对乳腺癌筛查工作产生了不利影响，特别是在早期发现疾病方面。卫生服务机构将重点转移到照顾 COVID-19 患者上，因此忽视了常规筛查计划和干预措施。此外，人们对感染的恐惧导致对筛查测试的需求下降。
